A patient with no previous history of vitiligo developed progressive vitiligo 2 years after receiving treatment with an immunocompetent vaccine for Stage D colorectal carcinoma. The patient's prolonged survival with metastases to the liver suggests the possibility of an immunologic response to the tumor vaccine associated with vitiligo. Although vitiligo has been reported in association with gastrointestinal carcinomas in the past, this is the first reported case following experimental autologous tumor vaccine therapy.
|Original language||English (US)|
|Number of pages||6|
|State||Published - Jan 1 1995|
ASJC Scopus subject areas
- Microbiology (medical)